Hippo and Wnt Signaling in Cardiac Regeneration

Information

  • Research Project
  • 10063539
  • ApplicationId
    10063539
  • Core Project Number
    R01HL127717
  • Full Project Number
    5R01HL127717-06
  • Serial Number
    127717
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    1/15/2016 - 9 years ago
  • Project End Date
    12/31/2023 - a year ago
  • Program Officer Name
    SCHWARTZ, LISA
  • Budget Start Date
    1/1/2021 - 4 years ago
  • Budget End Date
    12/31/2021 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
  • Award Notice Date
    1/23/2021 - 4 years ago
Organizations

Hippo and Wnt Signaling in Cardiac Regeneration

This R01 application will investigate a novel signaling pathway, the Hippo pathway, in mammalian heart regeneration. The long-term goal is to develop new treatments for patients with heart failure by generating new cardiomyocytes in the adult heart. The objectives of this application are to gain insight into molecular properties of cardiac tissue that are regulated by Hippo signaling. The central hypothesis is that Hippo signaling is a negative regulatory pathway that prevents cardiomyocyte regeneration in the adult mammalian heart. The specific aims are to determine whether the Hippo and Wnt pathways regulate adult heart repair in a manner similar to the interaction in neonatal hearts. To determine whether an autonomous Wnt Hippo interaction occurs in heart muscle nuclei to control important genes and to investigate whether Hippo functions in a reversible manner. The project is conceptually and technically innovative. Concepts to be tested include new ideas in cardiomyocyte biology and cutting edge genome editing and interrogation technologies to address hypotheses. The significance is high because there are no treatments for heart failure due to cardiomyocyte loss. Devising ways to generate new cardiomyocytes is highly significant.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    325041
  • Indirect Cost Amount
    204776
  • Total Cost
    529817
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:529817\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CDD
  • Study Section Name
    Cardiovascular Differentiation and Development Study Section
  • Organization Name
    TEXAS HEART INSTITUTE
  • Organization Department
  • Organization DUNS
    086987831
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    772250345
  • Organization District
    UNITED STATES